Clinical Trial Update: Effects of Cofrogliptin on Beta-Cell Function in LADA Patients [NA]

View source ↗

Summary

An update on a clinical trial evaluating Cofrogliptin for beta-cell function in latent autoimmune diabetes in adults, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Autoimmune Diabetes in Adults

Drugs mentioned

• Cofrogliptin (Cofrogliptin)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Latent Autoimmune Diabetes in Adults (LADA) | NA | Status: NOT_YET_RECRUITING